| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/18/2014 | US20140271908 Dietary supplements and methods for preventing and treating migraines |
| 09/18/2014 | US20140271907 Compositions comprising eicosapentaenoic acid and krill oil and methods of use thereof |
| 09/18/2014 | US20140271906 Ngna compositions and methods of use |
| 09/18/2014 | US20140271904 Methods for preparing tissue implants |
| 09/18/2014 | US20140271868 Treatment of achondroplasia with encapsulated cnp-secreting cells |
| 09/18/2014 | US20140271843 Multi-Layer Hydrogel Capsules for Encapsulation of Cells and Cell Aggregates |
| 09/18/2014 | US20140271790 Fascia fibrous compositions and methods for their use and manufacture |
| 09/18/2014 | US20140271784 Decellularized omentum matrix and uses thereof |
| 09/18/2014 | US20140271778 Encapsulated kidney tissue |
| 09/18/2014 | US20140271776 Preparations Derived From Placental Materials and Methods of Making and Using Same |
| 09/18/2014 | US20140271767 Biocompatible hydrogel polymer matrix for delivery of cells |
| 09/18/2014 | US20140271725 Small Molecule Enhancer for Dendritic Cell Cancer Vaccines |
| 09/18/2014 | US20140271692 Novel immunogenic epitopes for immunotherapy |
| 09/18/2014 | US20140271683 Therapeutic and Diagnostic Methods for Manipulating Phagocytosis Through Calreticulin and Low Density Lipoprotein-Related Receptor |
| 09/18/2014 | US20140271677 Newcastle Disease Viruses and Uses Thereof |
| 09/18/2014 | US20140271657 Combinatorial compositions and methods of treating hemoglobinopathies |
| 09/18/2014 | US20140271618 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 09/18/2014 | US20140271616 Compositions And Methods For Mesenchymal And/Or Chondrogenic Differentiation Of Stem Cells |
| 09/18/2014 | US20140271613 Surgical Compositions |
| 09/18/2014 | US20140271591 Compositions and methods for the modulation of hemoglobin (s) |
| 09/18/2014 | US20140271590 Methods for production of platelets from pluripotent stem cells and compositions thereof |
| 09/18/2014 | US20140271589 Treatment of collagen defects using protein solutions |
| 09/18/2014 | US20140271588 Treatment of peripheral vascular disease using protein solutions |
| 09/18/2014 | US20140271587 Treatment of inflammatory respiratory disease using biological solutions |
| 09/18/2014 | US20140271586 Nutritional Composition Containing a Peptide Component with Adiponectin Simulating Properties and Uses Thereof |
| 09/18/2014 | US20140271585 Treatment of chronic idiopathic emesis in felines and canines |
| 09/18/2014 | US20140271584 Methods and Compositions for Direct Reprogramming of Somatic Cells to Stem Cells, and Uses of these Cells |
| 09/18/2014 | US20140271580 Immunoprotective primary mesenchymal stem cells and methods |
| 09/18/2014 | US20140271578 Renal stem cells isolated from kidney |
| 09/18/2014 | US20140271576 Self-Gelling Alginate Systems and Uses Thereof |
| 09/18/2014 | US20140271574 Methods and compositions for treating congestive heart failure |
| 09/18/2014 | US20140271573 Pharmaco-cellular therapeutic method for the treatment of muscular dystrophies |
| 09/18/2014 | US20140271572 Adipose tissue mesenchymal stem cells and methods of use to treat or inhibit uterine disorders |
| 09/18/2014 | US20140271571 Cell Culture Cassettes and Incubator |
| 09/18/2014 | US20140271569 Kits and methods for processing stem cells from bone marrow or umbilical cord blood |
| 09/18/2014 | US20140271568 Method and kit for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, cxc chemokine receptor 4, and/or immune regulatory factor of stem cell |
| 09/18/2014 | US20140271567 Methods of treating or preventing rheumatic disease |
| 09/18/2014 | US20140271564 Vesicular stomatitis viruses containing a maraba virus glycoprotein polypeptide |
| 09/18/2014 | US20140271563 Effect of an attenuated bordetella strain against allergic disease |
| 09/18/2014 | US20140271562 Composition for use in brain growth and/or cognitive and/or psychomotor development |
| 09/18/2014 | US20140271561 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
| 09/18/2014 | US20140271558 Dietary Supplements Including Glucan and Fulvic Acid |
| 09/18/2014 | US20140271557 Methods of diagnosing and treating cancer by detecting and manipulating microbes in tumors |
| 09/18/2014 | US20140271554 Reducing Proinflammatory Response |
| 09/18/2014 | US20140271553 Nutritional Compositions Containing A Peptide Component with Anti-Inflammatory Properties and Uses Thereof |
| 09/18/2014 | US20140271552 Nutritional Compositions Containing a Peptide Component and Uses Thereof |
| 09/18/2014 | US20140271549 Use of Antibiotics to Enhance Treatment With Therapeutic Viruses |
| 09/18/2014 | US20140271480 Uses of indole-ketones or indolidones as neuro-protective drugs |
| 09/18/2014 | US20140271472 Methods and devices for lung volume reduction with extracellular matrix material |
| 09/17/2014 | EP2778223A1 Vascular progenitor cell sheet derived from induced pluripotent stem cells, and production method therefor |
| 09/17/2014 | EP2777703A1 Compositions and methods for enhancing the therapeutic potential of stem cells |
| 09/17/2014 | EP2776454A1 Modified neurotoxins with poly-glycine and uses thereof |
| 09/17/2014 | EP2776057A1 Methods of cardiac repair |
| 09/17/2014 | EP2776049A1 Malignant tumor treatment agent and food and drink including same |
| 09/17/2014 | EP2776048A1 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| 09/17/2014 | EP2776047A1 Treatment of red blood cells |
| 09/17/2014 | EP2776033A1 Dual inhibitor of met and vegf for treating cancer |
| 09/16/2014 | US8835170 Methods and compositions useful for diabetic wound healing |
| 09/16/2014 | US8835166 Extracellular matrix material created using non-thermal irreversible electroporation |
| 09/16/2014 | US8835163 Embryonic-like stem cells derived from adult human peripheral blood and methods of use |
| 09/16/2014 | US8835104 Medium and methods for the storage of platelets |
| 09/16/2014 | US8834936 Cosmetic compositions comprising asteroidea body fluid and methods of use thereof |
| 09/16/2014 | US8834914 Treatment methods using a particulate cadaveric allogenic juvenile cartilage particles |
| 09/16/2014 | US8834905 Wound dressing compositions |
| 09/16/2014 | US8834902 Biodegradable supporting device |
| 09/16/2014 | US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 09/16/2014 | US8834878 Antigen-antibody cancer recognition system |
| 09/16/2014 | US8834872 Uses of antibodies |
| 09/16/2014 | US8834868 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 09/16/2014 | US8834864 Methods for repairing and regenerating human dura mater |
| 09/16/2014 | CA2673337C Bone growth particles and osteoinductive composition thereof |
| 09/16/2014 | CA2527750C A dried product and a process for manufacturing the product |
| 09/16/2014 | CA2438501C Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 09/15/2014 | CA2846318A1 Enhanced medical implant |
| 09/15/2014 | CA2845390A1 Methods for segregating particles using an apparatus with a size-discriminating separation element having an elongate leading edge |
| 09/12/2014 | WO2014138710A1 Stem cell compositions and methods for wound healing |
| 09/12/2014 | WO2014138704A1 Targeting cd138 in cancer |
| 09/12/2014 | WO2014138671A2 Cryopreservation, hibernation and room temperature storage of encapulated pancreatic endoderm cell aggregates |
| 09/12/2014 | WO2014138612A1 Consistent calcium content bone allograft systems and methods |
| 09/12/2014 | WO2014138556A1 Kits and methods for the treatment of cancer using gliadin peptides |
| 09/12/2014 | WO2014138485A1 Ex vivo production of platelets from hematopoietic stem cells and the product thereof |
| 09/12/2014 | WO2014138383A1 Isolation of stromal vascular fraction from vascular tissues |
| 09/12/2014 | WO2014138348A1 Iikaros inhibition to augment adoptive t cell transfer |
| 09/12/2014 | WO2014138324A1 Compositions and methods for bacterial delivery of polypeptides |
| 09/12/2014 | WO2014138315A1 Heparanase expression in human t lymphocytes |
| 09/12/2014 | WO2014138314A1 Oncolytic virus |
| 09/12/2014 | WO2014138306A1 Engager cells for immunotherapy |
| 09/12/2014 | WO2014137234A1 Method for fasting-diet therapy |
| 09/12/2014 | WO2014137211A1 Use of faecali bacterium prausnitzii htf-f (dsm 26943) to suppress inflammation. |
| 09/12/2014 | WO2014136932A1 Anti-inflammatory agent |
| 09/12/2014 | WO2014136931A1 Infection protection agent |
| 09/12/2014 | WO2014136845A1 Method for producing mature dendritic cell population |
| 09/12/2014 | WO2014136453A1 C12orf48 PEPTIDES AND VACCINES CONTAINING THE SAME |
| 09/12/2014 | WO2014136048A1 Formulations of organic compounds |
| 09/12/2014 | WO2014136038A1 Hard capsule formulation |
| 09/12/2014 | WO2014135934A1 Camelid compound(s), composition(s) and method(s) |
| 09/12/2014 | WO2014135803A1 Use of attenuated parasite strains for the prevention and/or treatment of eye wounds associated with an infection by toxoplasma gondii |
| 09/12/2014 | WO2014134833A1 Edible composition, preparation method therefor, and food product comprising the composition |
| 09/12/2014 | WO2014134756A1 Topical hemorrhoid medicine |
| 09/11/2014 | US20140255508 Micronized placental tissue compositions and methods of making and using the same |